WuXi Biologics USA LLC

About WuXi Biologics USA LLC

WuXi Biologics is a leading contract research, development and manufacturing organization providing end-to-end capabilities to healthcare organizations worldwide. With operations in the United States, Ireland, Germany, Singapore and China, we enable our partners to effectively and efficiently bring biologics and vaccines to patients worldwide through our comprehensive and high-quality drug development model.  WuXi XDC and WuXi Vaccines, two subsidiaries of WuXi Biologics, offer end-to-end platforms for the development and manufacture of bioconjugates and vaccines, respectively.

  • Country/Region:
    United States
  • On CPHI since:
    2024
  • Employees:
    5000+
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Animal Health
Contract Manufacturer
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

WuXi Biologics USA LLC Resources (1)

  • Brochure WuXi Biologics Capabilities Overview

    As a leading CRDMO, WuXi Biologics integrates biologics services from concept through commercialization, delivering quality at every stage. We perform under the most demanding conditions, advancing programs at unmatched speed with expertise and assurance. Multi-modality discovery generates development-ready assets built for continuity. A growing pipeline supports over 660 IND approvals and25 commercial manufacturing programs. DNA reaches IND in as little as 6 months.